Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX Expands its iChemistry™ Solutions Portfolio with Sensitivity-enhancing Reagents for Mass Spectrometry

Published: Thursday, May 24, 2012
Last Updated: Thursday, May 24, 2012
Bookmark and Share
Amplifex™ reagents support the company’s strategy to push the limits of detection.

AB Sciex Pte. Ltd has announced the commercial availability of Amplifex™ Reagents, the first of a new family of advanced chemistries designed to boost the performance of mass spectrometers, improve data precision and significantly increase sensitivity beyond conventional limits.

The new reagents join the industry-leading iTRAQ® reagents for proteomics and IDQuant™ standards for pesticide analysis in the company’s intelligently-designed portfolio of mass spectrometry-based tagging chemistries, now called SCIEX iChemistry™ Solutions.

Industry research scientists will be presenting their novel work using these reagents at the ASMS conference in Vancouver this week.

Today, scientists around the world are working on assays that require levels of quantitation not possible with even the most sensitive and robust mass spectrometry instruments.

While mass spectrometry is a powerful technology for compound detection and quantitation, sensitivity can sometimes be negatively impacted by matrix suppression, high background noise levels, poor ionization efficiency or poor compound fragmentation.

With the Amplifex™ Reagents, improvements in sensitivity, compared to even the most sensitive of mass spectrometry instruments, can range from 5x to 1000x, depending on the analyte.

Amplifex™ Reagents are the only derivatizing agents custom designed, synthesized and tested to boost ionization efficiency, improve fragmentation and chromatographic properties, and overcome other workflow restraints that laboratories can face, including minimal available sample volumes.

Among the laboratories that had early access to the new Amplifex™ Reagents was the Wisconsin National Primate Research Center & Institute for Clinical & Translational Research at the University of Wisconsin-Madison.

As part of their study into the metabolomics systems of primates, scientists had struggled to achieve the sensitivity levels necessary to examine 1α,25-Dihydroxyvitamin D3.

After incorporating the new Amplifex™ Diene reagent into their workflow however, their sensitivity dilemma was solved.

“Using Amplifex™ Diene, we were able to achieve LOD of 2 pg/ml on the QTRAP® 5500 system for both 1α,25-Dihydroxyvitamin D3 and 1α,25-Dihydroxyvitamin D2, starting with a sample volume of 200 µL, thereby using half the serum volume we would otherwise have used,” said Toni E. Ziegler, Ph.D., Wisconsin National Primate Research Center & Institute of Clinical & Translational Research, University of Wisconsin-Madison. “Through the use of intelligent chemistry, AB SCIEX is pushing the limits of sensitivity to levels unachievable with current LC/MS/MS methods.”

As part of her research into biomarker discovery for Cerebrotendinous Xanthomatosis disease, the new Amplifex™ Keto reagent enabled a scientist at Oregon Health & Science University to successfully measure low concentrations of specific ketosterols, despite the sensitivity and low sample volume requirements necessary for her research.

“The new Amplifex™ Keto reagent is very easy to use and fast, and it enabled me to achieve sensitivity levels of 2.5-5 pg/ml using only 5ml plasma,” said Andrea DeBarber, PhD., Research Assistant Professor, Physiology & Pharmacology Department, Associate Director, Bioanalytical Shared Resource Facility, Oregon Health & Science University. “I agree that the new Amplifex reagent is truly expanding the boundaries of sensitivity for ketosterol biomarker quantification.”

iTRAQ® and the new Amplifex™ Reagents are a part of a family of SCIEX iChemistry™ Solutions, the world’s only reagents and consumables custom designed for mass spectrometry applications.

“We are not only pushing the limits of sensitivity through instrumentation, but we are also pushing the limits through chemistry,” said Babu Purkayastha, Director of R&D for Consumables at AB SCIEX. “We are known for our iTRAQ chemistries, and with our new Amplifex reagents, we are once again enabling researchers to perform challenging analyses and workflows by mass spectrometry, so they can address key analytical and biological questions. Going forward, we will continue to innovate in this area of advanced chemistries.”

Derivatization is no longer a painful, day-long process. With Amplifex™ Reagents, sample preparation workflows are quick, simple, reproducible and robust as well as yielding higher recoveries than traditional reagents. The first two sets of reagents in the Amplifex™ line are:

• Amplifex™-Diene Reagent - a reagent that can be used to derivatize any molecule with a cis-diene system, including compounds such as Vitamin D3 and Vitamin D2 analogs, such as 1α, 25-Dihydroxyvitamin D3 and 1α, 25-Dihydroxyvitamin D2, among others. The result is a signal enhancement of up to 1000-fold.

• Amplifex™-Keto Reagent - a reagent that is universal and reacts with keto or aldehyde compounds, including ketosteroids, such as testosterone, among others. Signal enhancements improve mass limits of detection by up to 500-fold.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIEX, QPS Holdings Collaborate
Agreement aims to advance the hybrid LBA-LCMS workflow for biologics quantification.
Wednesday, April 06, 2016
SCIEX, Children's Medical Research Institute Collaborate
SCIEX industrialized proteomics solutions, using SWATH® Acquisition-based workflows and powered by the OneOmics™ Project, will enable large scale proteome studies to advance cancer research.
Thursday, February 11, 2016
SCIEX, A*STAR’s BTI Launch Collaboration
Agreement aims to boost innovation of protein drugs that target new diseases and are safer for patients.
Wednesday, January 27, 2016
SCIEX, Pressure BioSciences Partner
SCIEX and Pressure BioSciences to offer complete solution for next-generation proteomics, to increase the reproducibility and depth of proteomic analysis.
Wednesday, January 13, 2016
SCIEX, University of Manchester Partner
SWATH® Acquisition-based next-generation proteomics technology promises to make industrial proteomics a reality.
Thursday, October 29, 2015
SCIEX Partners with the Paulovich Lab at Fred Hutchinson Cancer Research Center
Collaboration targets research reproducibility crisis with highly validated multiplex quantitation assays.
Wednesday, September 23, 2015
SCIEX and New Objective Announce Partnership
New nanospray sources to offer maximum sensitivity and robustness for NanoLC-MS.
Tuesday, June 02, 2015
SCIEX and New Objective Partner
Partnership will provide advanced nanospray ionization technologies for next-generation proteomics.
Tuesday, May 26, 2015
SCIEX and Hepregen Announce Co-Marketing Agreement
Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.
Friday, May 22, 2015
SCIEX and Mass Consortium Corporation Announce Exclusive Reseller Agreement
SCIEX to provide customers with XCMSplus software solution for simplified and accelerated metabolomics workflows.
Tuesday, March 31, 2015
SCIEX and Labor Berlin Collaboration to Advance Forensic Testing
Collaboration for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library.
Thursday, March 05, 2015
New Capabilities for Bioanalysis Studies at the International Pharmaceutical Research Center
AB SCIEX Triple Quad™ 6500 LC/MS/MS systems enable new levels of sensitivity for clinical trials of inhaled drugs.
Wednesday, February 11, 2015
Improved Accuracy of Pesticide Detection in Food
European Reference Laboratory improves accuracy of pesticide detection in food with AB SCIEX mass spectrometry instrumentation.
Wednesday, February 04, 2015
AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
AB SCIEX Scientist Wins HUPO 2014 Science and Technology Award
Winner becomes second team member to be recognized for the commercialization of transformative chemistries such as iTRAQ® eagents.
Monday, October 06, 2014
Scientific News
Detecting Fake Parmesan Cheeses
Scientists report on a way to catch adulteration of the regional artisanal products.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Process Analysis in Real Time
With a real-time mass spectrometer developed by Fraunhofer researchers, it has become possible for the first time to analyze up to 30 components simultaneously from the gas phase and a liquid, including in-situ analysis.
Triple-Negative Breast Cancer Target Is Found
Researchers at UC Berkeley discover a target that drives cancer metabolism in triple-negative breast cancer.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
A Mechanistic Tool for Studying Fungal Pathogens
This study presents an overview of lipid extraction, chromatographic separation and mass spectrometry employed in qualitative and quantitative sphingolipidomics in fungi.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
HIV Particles Used to Trap Intact Mammalian Protein Complexes
Belgian scientists from VIB and UGent developed Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Coding and Computers Help Spot Methane, Explosives
Coded apertures improve and shrink mass spectrometers for field use.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!